Assignment of Trademarks. Anteris shall assign to vTv all of Anteris’ and its controlled (within the meaning of Section 1.4) Affiliates’ right, title and interest in any product trademark used solely with and for any Licensed Products, along with all associated goodwill, but specifically excluding any corporate trademarks or trade names of Anteris or such controlled Affiliates or any goodwill associated therewith.

Assignment of Trademarks. Assign to vTv all of Newsoara’s right, title and interest in any trademark used solely in connection with the Products, along with all associated goodwill.

Assignment of Trademarks. At vTv’s option, to be exercised no later than ​ days after the effective date of termination, Huadong shall negotiate in good faith to assign to vTv ​ all of Huadong’s right, title and interest in any trademark used solely in connection with the Products, along with all associated goodwill.

Trademarks. Licensee may, at its sole discretion, elect to use any Trademark which it owns or has exclusive rights to (Licensee-Controlled Trademark) in connection with its Commercialization of the Licensed Products in the Territory (provided that Licensee discusses the use of such Licensee‑Controlled Trademark with Bioeq and takes into account Bioeq’s global branding strategy for the Licensed Products).

Trademarks. [Section 5.7.1] of the Agreement shall not apply with respect to any Profit Share Product. In addition to the other provisions of the Agreement (and in lieu of [Section 5.7.1] of the Agreement), the following terms of this Article VII shall apply to the Product Trademarks relating to the Profit Share Products during the Profit Share Terms.

Trademarks. Astellas shall transfer and assign, and shall ensure that its Affiliates transfer and assign, to [[Cytokinetics:Organization]], at no cost to [[Cytokinetics:Organization]], all Product Marks relating to any [ * ] Product and any applications therefor (excluding any such marks that include, in whole or part, any corporate name or logos of Astellas or its Affiliates or sublicensees). [[Cytokinetics:Organization]] and its Affiliates and licensees shall have the right to use other identifiers specific to such [ * ] Product (e.g., Astellas compound identifiers). Astellas shall also transfer to [[Cytokinetics:Organization]] any in-process applications for generic names for any [ * ] Product.

Subject to review and discussion by the JSC, Lian will have the right to brand the Licensed Products in the Field in the Territory using Lian related Trademarks and any other Trademarks and trade names it determines appropriate for the Licensed Products, which branding may vary by Region or within a Region. Lian will own all rights in such Trademarks and register and maintain such Trademarks in the countries and regions within the Territory, where and how it determines appropriate.

Trademarks. Abbott shall select the Product Trademark under which each Co-Promoted Product shall be marketed. The Parties shall market each Co-Promoted Product in the Co-Promotion Territory exclusively under such Product Trademark (all such trademarks being hereinafter referred to as the “Co-Promotion Trademarks”), and Abbott shall grant Enanta a license to use such Co-Promotion Trademarks solely for such Co-Promotion. Abbott shall register the Co-Promotion Trademarks in the Co-Promotion Territory and shall take all such actions as are required to continue and maintain in full force and effect in the Co-Promotion Territory the Co-Promotion Trademarks and the registrations thereof, and shall be solely responsible for all expenses incurred in connection therewith. As between the Parties, Abbott shall be the exclusive owner of the Co-Promotion Trademarks in the Co-Promotion Territory.

Trademarks. Except if this Agreement is terminated by [[3D Medicines:Organization]] pursuant to [Sections 13.4 or 13.5]5], upon [[Aravive:Organization]]’s written request, [[3D Medicines:Organization]] shall grant to [[Aravive:Organization]], effective as of the date of such request, an exclusive, transferable, fully paid-up, royalty free, sublicensable license to use [[3D Medicines:Organization]] Product Marks in connection with the Commercialization of Licensed Products in the [[3D Medicines:Organization]] Territory (and excluding, for clarity, any [[3D Medicines:Organization]] Housemarks).

Trademarks. Acadia will solely own all right, title and interest in and to any trademarks adopted for use with the Licensed Products in the Field in the Territory, and will be responsible for the registration, filing, maintenance and enforcement thereof. Neither Stoke nor any of its Affiliates will at any time do or authorize to be done any act or thing which is likely to materially impair the rights of Acadia therein, and will not at any time claim any right of interest in or to such marks or the registrations or applications therefor. Neither Stoke nor any of its Affiliates will use Acadia’s or any of its Affiliates’ trademarks or any confusingly similar trademarks in a manner that might amount to infringement, dilution, unfair competition or passing off of any of Acadia’s or any of its Affiliates’ trademarks without Acadia’s consent.